CDER Conversation on Crowdsourcing Pediatric Regulatory Science Research Question – Drug Information Update

If your email program has trouble displaying this email, view it as a web page. CDER Conversation on Crowdsourcing Pediatric Regulatory Science Research Question  FDA's Center for Drug Evaluation and Research's (CDER) Office of Strategic Programs (OSP) recently partnered with CDER's Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, Division of Pediatrics and Maternal Health (DPMH) to launch an external crowdsourcing challenge (closing August 20, 2021) to collect ideas about topics the public thinks FDA scientists should research using data from multiple pediatric clinical trials. In this CDER Conversation, Kimberly Taylor, Director of OSP's Program Evaluation and Implementation Staff, and Lynne Yao, Director of the Division of Pediatrics and Maternal Health speak about external crowdsourcing and why DPMH decided to partner with OSP to collect innovative ideas for pediatric regulatory research questions from its external stakeholders. Learn More This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA